AzTrials
AzTrials

Cognitive ImpairmentCAPSULARNCT07470216

Cognitive Assessment And Post-Operative Complications After Surgery: Linking Anaesthesia And Risk

An observational study of Cognitive Impairment and Cognitive Impairment, Mild, run by University of Edinburgh at 1 site in United Kingdom.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Many older people can experience confusion, memory problems, or a decline in their thinking after major surgery. These problems are sometimes called 'postoperative neurocognitive disorders' or PND and can affect recovery and a person's ability to live independently. Read more about this study

Who is it for?
Ages 70 years and olderHealthy volunteers can take part
What is being tested?
Montreal Cognitive Assessment and biomarkers
How many people
40 participants
Where
1 siteUnited Kingdom
Study dates
Nov 2026to Mar 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 70 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Study population: We will conduct a prospective, single-centre feasibility cohort study over a period of 24 months, recruiting patients from the Perioperative medicine for Older People having Surgery clinic (POPS) clinic at the Western General Hospital, Edinburgh, who are scheduled for major surgery. This is a pre-surgery clinic and physician-led inpatient follow up service with discharge planning roles. Note, the nature of the clinical pathway means that patients may wait several months from POPS clinic review until surgery.

Who may be able to join

  • Age ≥ 70
  • Seen in the Perioperative medicine for Older People undergoing Surgery (POPS) clinic
  • Scheduled for colorectal or urological surgery with expected anaesthesia time over 60 minutes

Who cannot join

  • Regional anaesthesia only
  • Planned day surgery or expected hospital stay < 24 hours
  • Expected to remain sedated and ventilated for > 24 hours postoperatively
  • Participant does not wish to remain in the study if capacity is lost during the study
  • CO-ENROLMENT
  • As this is a non-intervention study, co-enrolment will be permitted in other studies that do not conflict with this protocol.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Kieran P Nunn, MB BS, BSc(h), FRCA, FFICM contact

+441315371652

kieran.nunn@nhs.scot

Zoeb Jiwaji, MBBCh, PhD, MRCP, FRCA, FFICM contact

+441315371652

zoeb.jiwaji@ed.ac.uk

United Kingdom1 site
  • Western General Hospital

    Edinburgh, Midlothian, EH4 2XU

    Kieran P Nunn, MBBS, BSc (hons), FRCA, FFICM, +441315371652, kieran.nunn@nhs.scot

    Zoeb Jiwaji, MBBCh, PhD, MA, +441315371652, zoeb.jiwaji@ed.ac.uk

Other trials in United Kingdom

About this study

Many older people can experience confusion, memory problems, or a decline in their thinking after major surgery. These problems are sometimes called 'postoperative neurocognitive disorders' or PND and can affect recovery and a person's ability to live independently.

The investigators want to find out the best way to study these problems in older patients undergoing surgery. This is a 'feasibility study', which means we are testing the research methods. The investigators want to see if it is possible to ask participants to do memory tests and give blood samples before and after their operation. The investigators are hoping to include around 40 patients over 2 years in this study.

Read more

The investigators will compare performance in memory (cognitive assessment) findings before and after surgery and link this to data taken from the anaesthetic, including the types of drugs used, duration, brain features from processed electroencephalogram monitoring and standard recommended monitoring. In addition the investigators will link this to blood sample markers of brain health and function (biomarkers).

The results of this study will help the investigators plan a much larger study in the future, with the ultimate goal of making surgery safer for the brain.

Read the detailed description

SUMMARY

Older patients can experience significant difficulties with memory and thinking (known as cognitive problems) after major surgery. The specific reasons in this vulnerable group are not yet clearly understood.

CAPSULAR is a single-centre feasibility research project at the Western General Hospital, Edinburgh, that aims to find the best way to conduct detailed research into this problem.

Objectives:

Main Aim:

  • To determine if it is practical and feasible to screen older participants (age ≥ 70) for cognitive problems both before surgery and up to 7 days after surgery (or before leaving hospital, if earlier).

Secondary Aims:

  • Collect extra blood samples (at the same time as routine clinical blood tests) to measure markers of potential brain injury. These will be collected before, immediately after, and up to 7 days after surgery (or before leaving hospital, if earlier).
  • Gather detailed data on the participant's health, frailty, and the anaesthetic technique used, including standard brain monitoring (pEEG) to monitor anaesthesia depth during the operation.
  • Look for a link between anaesthesia technique and the risk of cognitive problems and blood markers of brain injury.
  • Proxy outcomes to inform economic analysis in a larger planned trial e.g. impact on changes in care need, cognitive aids such as new use of a multi-compartment drug compliance aid.

We plan to recruit 40 patients aged ≥ 70 who are scheduled for colorectal or urological surgery lasting over one hour. Participants will be those already attending the POPS (Perioperative Medicine for Older People undergoing Surgery) clinic.

The study will measure success based on the percentage of eligible patients who agree to take part, complete the one-week cognitive screening, and provide all the necessary blood and data samples.

This research will provide the crucial initial evidence needed to plan future definitive trials exploring whether altering anaesthetic or surgical care can safely reduce brain problems for older and frailer patients.

2 INTRODUCTION

2.1 BACKGROUND

Postoperative neurocognitive disorders (PND) represent a spectrum of cognitive impairments that can arise after surgery, ranging from acute, reversible, postoperative delirium to more persistent, and sometimes subtle, cognitive decline. These disorders are particularly common in older adults, with reported incidence rates for postoperative delirium as high as 40% following major elective surgery. The consequences are significant, including prolonged hospital stays, increased patient morbidity and mortality, and a greater likelihood of long-term cognitive impairment, which can profoundly reduce a patient's quality of life and independence. Additionally, there may be further impact economically and upon the formal and informal care sectors for example new dependence on aids.

The investigators' previous work with the Perioperative Care for Older People Undergoing Surgery (POPS) Clinic at the Western General Hospital, Edinburgh, identified that 21% of patients scheduled for major surgery had previously unrecognised pre-operative cognitive impairment. This cohort subsequently experienced a high incidence of PND, particularly delirium, affecting 40% of those who underwent emergency surgery and 5% of those undergoing elective surgery. This highlights a vulnerable patient population in whom the risks of postoperative cognitive decline are substantial.

The pathophysiology of PND is thought to be multifactorial, involving interplay between patient-specific risk factors (e.g., advanced age, frailty, pre-existing cognitive deficits) and procedural factors, such as surgical stress, systemic inflammation, and anaesthetic technique. Previous research has often included younger and less frail individuals, leaving a critical knowledge gap concerning those elderly and frailer patients who are possibly most at risk.

Given the increasing trend towards older patients undergoing major surgery, there is therefore, an urgent need for research focused specifically on elderly and frail patients to identify reliable risk factors. This includes physiological and molecular biomarkers predictive of PND. This knowledge will enable us to better identify at-risk patients to inform consent, guide preventative resources, and stratify participants for future trials of therapeutic interventions.

2.2 RATIONALE FOR STUDY

One near-universal criticism of the existing literature in this area has been that study cohorts have not been of a sufficiently advanced age. The investigators' research location hospital and clinic stream enables them to set recruitment at 70 years of age or over, as one in five, over-75 year olds, are predicted to undergo surgery from 2030.

While the pilot data established a high incidence of PND in a high-risk cohort, the investigators now need to investigate and categorise the nature of PND with greater accuracy and determine if it is feasible to robustly investigate the impact of perioperative factors on cognitive outcomes.

This project aims to address this evidence gap. The investigators will conduct a prospective feasibility study to establish the practicalities of performing detailed, domain-specific cognitive testing in a high-risk, frail, older patient population at baseline (preoperatively) and postoperatively. This will allow them to accurately quantify the incidence of new or worsening cognitive impairment following major surgery. Furthermore, the investigators will assess the feasibility of systematically collecting detailed data on anaesthetic technique, including intra-operative processed EEG metrics, and obtaining serial blood samples for biomarker analysis. Finally the investigators will assess proxy- patient impact and economic markers such as predicted vs. actual length of stay, change to living arrangements and provision of new aids.

The investigators hypothesize that it is feasible to recruit this cohort and perform these detailed assessments. This work is critical as it will provide the foundational data necessary to design a larger, adequately powered trial to determine whether specific anaesthetic practices, such as pEEG-guided anaesthesia to minimise burst suppression, can mitigate the risk of long-lasting postoperative cognitive decline in vulnerable patients. It will inform the design of research aimed at generating data to help identify at-risk patients, possibly identify modifiable factors and quantify the incidence which would help improve the accuracy of pre-surgery counselling.

Being tested
Montreal Cognitive Assessment, biomarkers
Keywords
cognitive impairment, cognitive impairment, mild, cognitive impairment, progressive, anesthesia, anesthesia brain monitoring, anesthesia depth monitoring
Medical subject headings
Cognitive Dysfunction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Montreal Cognitive AssessmentOther

    Preoperative and Postoperative MoCA

  • biomarkersDiagnostic test

    • Pre-operatively: sample collected at a suitable time of blood draw for routine peri-operative clinical samples or insertion of a peripheral venous cannula as part of routine anaesthetic care after consent and enrollment. This may be in the POPS clinic or on day of admission for surgery or when canulated for anaesthesia.
    • Immediate post-operative period: sample collected in recovery or on the ward at the first ordered routine blood-draw.
    • Up to 7 days post-surgery: sample collected on the ward (or last anticipated routine sample).

    Biomarkers assessed will be a panel linked to brain injury, inflammation, and cognitive impairment in non-ICU populations.

Study groups in NCT07470216
Study groupRoleWhat they receive
Perioperative medicine for Older People undergoing Surgery (POPS) clinic patientsAge > 70, scheduled for colorectal or urological surgery with expected anaesthesia time over 60 minutes.
Receives: Other: Montreal Cognitive Assessment; Diagnostic Test: biomarkers

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The proportion of eligible patients who consent to participate and are successfully screened for delayed neurocognitive recovery up to discharge or 7 days, whichever is sooner.

    The overall aim is to test the feasibility of this research being conducted on a larger scale. The primary outcome assesses the proportion of eligible patients who consent and then undergo pre- and post-operative cognitive testing.

    Measured: Participants will be involved within the study from time of consent (expected at their POPS clinic visit) until up to 7-days after surgery or to hospital discharge (whichever is sooner).

Secondary outcomes (3)
  1. The proportion of consented patients from whom a complete set of blood samples (pre-anaesthesia, post-anaesthesia, and up to discharge or 7 days, whichever is sooner) is successfully collected and stored.

    The overall aim is to test the feasibility of this research being conducted on a larger scale. The outcome assesses the proportion of eligible patients who consent and then provide pre-, immediately-post-operative and pre-discharge biomarker blood samples (additional tubes/samples from routine blood-lets).

    Measured: Participants will be involved within the study from time of consent (expected at their POPS clinic visit) until up to 7-days after surgery or to hospital discharge (whichever is sooner).

  2. The proportion of consented patients for whom complete anaesthetic data, including depth of anaesthesia parameters, are successfully retrieved from electronic records.

    The overall aim is to test the feasibility of this research being conducted on a larger scale. The outcome assesses the proportion of eligible patients who consent and then have a complete intraoperative data-set collected.

    Measured: The time-gap between clinic and surgery depends upon many factors, as does post-operative duration. Participants will be involved within the study from time of consent until up to 7-days after surgery or to hospital discharge (whichever is sooner).

  3. The incidence and nature of PND identified through domain-specific cognitive testing.

    Analysis of the performance in the Montreal Cognitive Assessment (MoCA) tool allows us to both analyse incidence, but also features of, any identified cognitive changes across the timespan of the patients preparation and undertaking of surgery.

    Measured: Participants will be involved within the study from time of consent (expected at their POPS clinic visit) until up to 7-days after surgery or to hospital discharge (whichever is sooner).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Mar 2026
  2. Study startNov 2026 (estimated)
  3. Primary completionMar 2028 (estimated)
  4. Study completionMar 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07470216
Sponsor's protocol ID
AC25200
Acronym
CAPSULAR
Status last verified
Sep 2026
First submitted
10 Mar 2026
Last updated
24 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Evered L, Silbert B, Knopman DS, Scott DA, DeKosky ST, Rasmussen LS, Oh ES, Crosby G, Berger M, Eckenhoff RG; Nomenclature Consensus Working Group. Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery-2018. Br J Anaesth. 2018 Nov;121(5):1005-1012. doi: 10.1016/j.bja.2017.11.087. Epub 2018 Jun 15.

    PubMed 30336844
  • Monk TG, Weldon BC, Garvan CW, Dede DE, van der Aa MT, Heilman KM, Gravenstein JS. Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology. 2008 Jan;108(1):18-30. doi: 10.1097/01.anes.0000296071.19434.1e.

    PubMed 18156878
  • Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014 Mar 8;383(9920):911-22. doi: 10.1016/S0140-6736(13)60688-1. Epub 2013 Aug 28.

    PubMed 23992774
  • Subramaniyan S, Terrando N. Neuroinflammation and Perioperative Neurocognitive Disorders. Anesth Analg. 2019 Apr;128(4):781-788. doi: 10.1213/ANE.0000000000004053.

    PubMed 30883423

Questions about this trial

What is this clinical trial studying?

An observational study of Cognitive Impairment and Cognitive Impairment, Mild, run by University of Edinburgh at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 24 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Kieran P Nunn, MB BS, BSc(h), FRCA, FFICM (+441315371652, kieran.nunn@nhs.scot), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The proportion of eligible patients who consent to participate and are successfully screened for delayed neurocognitive recovery up to discharge or 7 days, whichever is sooner. (time frame: Participants will be involved within the study from time of consent (expected at their POPS clinic visit) until up to 7-days after surgery or to hospital discharge (whichever is sooner).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07470216, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in